In addition, several GLP-1RA have been shown to reduce a composite 3-point MACE outcome in large, randomized cardiovascular outcome trials
This research tool can help R&D teams find, organize, and simplify data with one simple query, like: What are the emerging therapeutic applications of GLP-1 receptor agonists in addiction medicine
Co-administration of pramlintide with either the sympathomimetic sibutramine or phentermine was observed to result in 9.2 kg weight loss compared with placebo over 24 weeks, whereas pramlintide monotherapy resulted in just 1.5 kg additional weight loss [79]
This dual action has been shown in clinical trials to produce significant reductions in HbA1c (a marker of long-term blood glucose control) and body weight, often outperforming medications that target only one hormone pathway
With consistent levels, you may notice improved mood regulation, better sleep quality, and a reduction in the pins and needles sensation
Short-chain fatty acids suppress food intake by activating vagal afferent neurons